Yumanity Therapeutics (FRA:8IY) Beginning Cash Position : €12.85 Mil (As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Beginning Cash Position?

Yumanity Therapeutics's Beginning Cash Position for the quarter that ended in Sep. 2022 was €12.85 Mil.

Yumanity Therapeutics's quarterly Beginning Cash Position declined from Mar. 2022 (€32.72 Mil) to Jun. 2022 (€16.02 Mil) and declined from Jun. 2022 (€16.02 Mil) to Sep. 2022 (€12.85 Mil).

Yumanity Therapeutics's annual Beginning Cash Position increased from Dec. 2019 (€4.66 Mil) to Dec. 2020 (€11.71 Mil) and increased from Dec. 2020 (€11.71 Mil) to Dec. 2021 (€73.35 Mil).

Yumanity Therapeutics Beginning Cash Position Historical Data

The historical data trend for Yumanity Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Beginning Cash Position Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Beginning Cash Position

4.66

11.71

73.35

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Beginning Cash Position	Get a 7-Day Free Trial							41.02	39.35	32.72	16.02	12.85

Yumanity Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Yumanity Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines